13.97 aHRAmong patients switching to dolutegravir-containing regimens, those with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 13.97 for pulmonary tuberculosis or a WHO clinical stage 4 event compared to those with preswitch viral load <200 copies/mL.
Kenyatuberculose · WHO clinical stage 4 eventpublished 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations
53 %By March 2007, the estimated proportional decline in paediatric malaria admissions was 53% in Kwale.
Kenyapaludismeobserved March 2007published 2007Malaria journaleurope_pmcdocument of 3 observations
2.32 per_100_person-yearsAmong newly enrolled adolescents and youth living with HIV (AYLHIV) in Kenya between January 2016 and December 2017, the incidence of mortality was 2.32 per 100 person-years.
KenyaVIH/sidaobserved 2016-2017published 2023AIDS patient care and STDsPubMeddocument of 5 observations
41.99 scoreQuality of life among cancer patients in Kenya had median scores ranging from 41.99 to 53.
Kenyacancer (non précisé)PubMeddocument of 11 observations
56.6 %HITSystem 2.0 participants were more likely to receive complete PMTCT services compared to standard of care (56.6% vs. 17.1%).
KenyaVIH/sidaobserved between November 2017 and June 2019published 2021AIDS and behaviorPubMeddocument of 2 observations
96 %Overall, service-based malaria vaccine coverage was 96% for dose 1 of RTS,S/AS01 in Kenya's pilot implementation.
Kenyapaludismeobserved 2019-2022published 2023Malaria journaleurope_pmcdocument of 10 observations
3.18 ORComa was associated with uraemia with an odds ratio of 3.18.
Kenyauraemiapublished 2021Malaria journalPubMeddocument of 14 observations
58 %Among 2311 virally unsuppressed adolescents and young adults living with HIV in Kenya with a repeat viral load test, 1330 (58%) had confirmed treatment failure.
KenyaVIH/sidaobserved April 2017 to May 2019published 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations
27.9 %Using PCR technique, the overall malaria positivity rate was 27.9% in pregnant women and children below five years seeking healthcare services at rural health facilities in Kwale and Siaya counties in Kenya.
Kenyapaludismepublished 2021PloS onePubMeddocument of 15 observations
30 %Klebsiella pneumoniae was present in 48 (30%) of 162 HIV-attributed infant or child deaths.
KenyaVIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations
2.26 aORPatients tested in hospitals were over two times as likely to have a new HIV diagnosis as those tested in smaller facilities (i.e., health centers and dispensaries) (aOR 2.26; 95% CI = 1.60–3.21).
KenyaVIH/sidaobserved 2018published 2022International journal of STD & AIDSPubMeddocument of 4 observations
18 %HIV prevalence among people who inject drugs in Kenya is estimated to be 18%.
KenyaVIH/sidapublished 2022Journal of substance abuse treatmentPubMeddocument of 7 observations
131 controlsA total of 131 controls were recruited in the study on ocular surface squamous neoplasia (OSSN) in Kenya.
Kenyaocular surface squamous neoplasia (OSSN)published 2016Tropical medicine & international health : TM & IHeurope_pmcdocument of 10 observations
1.74 odds_ratioModerate-to-severe depressive symptom risk was significantly increased with low social support (adjusted odds ratio 1.74 [95% CI 1.56–1.95]).
Kenyadepressive symptomspublished 2022The lancet. PsychiatryPubMeddocument of 9 observations
For R21/Matrix-M, higher frequencies of NANP-specific activated memory IgG B cells were detected in infants versus adults.
Kenyapaludismepublished 2026Frontiers in immunologyPubMeddocument of 5 observations
33.9 %Patients treated with injectable artesunate had a significantly increased cumulative incidence of discharge by 33.9%.
Kenyapaludismepublished 2022BMJ openPubMeddocument of 9 observations
18.2 per_100000In 2013–2015, head and neck cancer incidence was highest among SEER states at 18.2 per 100,000 among men.
KenyaHead and neck cancerobserved 2013-2015published 2021Cancer epidemiologyeurope_pmcdocument of 7 observations
73.2 %Access to HIV/AIDS information was 73.2% in non-intervention sites at end line.
KenyaVIH/sidapublished 2020African Journal of Health SciencesOpenAlexdocument of 7 observations
3.9 %HBV prevalence was 3.9% among males and 2.8% among females.
Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations
32 %Enterococcus species accounted for 32% of microorganisms causing catheter-associated urinary tract infection in the Kenyatta National Hospital critical care unit.
Kenyacatheter-associated urinary tract infectionobserved 2019–2020published 2020African Journal of Health SciencesOpenAlexdocument of 17 observations
96.2 %Among 210 prediabetic adults in Kenya, 96.2% had at least one additional metabolic abnormality alongside prediabetes.
Kenyaprediabetespublished 2026Diabetes research and clinical practicePubMeddocument of 6 observations
15.7 %Parasite prevalence was 15.7% in South Central Somalia.
Kenyapaludismeobserved 2007published 2008PloS oneeurope_pmcdocument of 5 observations
14.1 %The prevalence of cachexia among cancer out-patients in Nairobi, Kenya was 14.1%.
Kenyacancer (non précisé)published 2017Journal of nutritional scienceeurope_pmcdocument of 10 observations
77.2 %Sexual economic exchange was reported by 403 (77.2%) sexually active women among 536 sexually active women screened in Kisumu, Kenya from January 2017 to May 2018.
KenyaVIH/sidaobserved January 2017 to May 2018published 2025Archives of sexual behaviorPubMeddocument of 8 observations
14 casesReasons for exclusion at screening included hepatitis (n = 14).
Kenyahepatitispublished 2022BMC public healthPubMeddocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.